Adverum Biotechnologies Inc (ADVM)

전일 마감가:

$9.19

열려 있는:

$9.29

하루 거래량:

540.28K

시가총액:

$196.66M

수익:

-

순이익/손실:

$-117.17M

주가수익비율:

-7.1729

EPS:

-1.33

순현금흐름:

$-91.71M

1주 성능:

-15.87%

1개월 성능:

-32.53%

6개월 성능:

+904.32%

1년 성능:

+1,117%

1일 변동 폭

$8.76

$9.964

52주 변동 폭

$0.721

$17.65

Adverum Biotechnologies Inc Stock (ADVM) Company Profile

명칭

Adverum Biotechnologies Inc

부문

Healthcare (1203)

산업

Biotechnology (688)

전화

650-272-6269

주소

1035 O'Brien Drive, Suite A, Menlo Park, CA

직원

96

트위터

@adverumbio

다음 수익 날짜

2024-05-09

최신 SEC 제출 서류

ADVM's Discussions on Twitter

Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2022-07-07	업그레이드	Truist	Hold → Buy
2021-07-23	다운그레이드	Cantor Fitzgerald	Overweight → Neutral
2021-05-03	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2021-04-29	다운그레이드	Chardan Capital Markets	Buy → Neutral
2021-04-29	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2021-04-29	다운그레이드	Truist	Buy → Hold
2020-12-16	개시	UBS	Neutral
2020-11-12	업그레이드	Raymond James	Underperform → Mkt Perform
2020-06-26	다운그레이드	Raymond James	Mkt Perform → Underperform
2020-05-13	개시	RBC Capital Mkts	Outperform
2020-05-05	업그레이드	SunTrust	Hold → Buy
2020-04-28	개시	Goldman	Buy
2020-03-16	개시	SVB Leerink	Outperform
2020-02-10	업그레이드	Cantor Fitzgerald	Neutral → Overweight
2020-02-10	업그레이드	Chardan Capital Markets	Neutral → Buy
2019-10-15	재확인	Chardan Capital Markets	Neutral
2019-09-13	재확인	Chardan Capital Markets	Neutral
2019-06-14	재개	Raymond James	Mkt Perform
2018-11-02	다운그레이드	Raymond James	Outperform → Mkt Perform
2018-11-02	다운그레이드	SunTrust	Buy → Hold
2018-09-21	개시	Cantor Fitzgerald	Overweight
2018-08-30	개시	SunTrust	Buy
2018-02-15	재개	Piper Jaffray	Overweight
2017-10-12	개시	Raymond James	Outperform

모두보기

Adverum Biotechnologies Inc 주식(ADVM)의 최신 뉴스

Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting

GlobeNewswire Inc.

Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?

Zacks Investment Research

Down -24.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)

Zacks Investment Research

Are Medical Stocks Lagging Adverum Biotechnologies (ADVM) This Year?

Zacks Investment Research

How Adverum (ADVM) Stock Stands Out in a Strong Industry

Zacks Investment Research

Down -28.72% in 4 Weeks, Here's Why Adverum Biotechnologies (ADVM) Looks Ripe for a Turnaround

Zacks Investment Research

Adverum Biotechnologies Inc (ADVM) 재무 분석

Adverum Biotechnologies Inc (ADVM) 순이익 2024

Adverum Biotechnologies Inc (ADVM) 현금흐름 2024

Adverum Biotechnologies Inc (ADVM) 주당 순이익 2024

Adverum Biotechnologies Inc 주식 (ADVM) 내부자 거래